Ok so neu has made it very clear that tox studies and commercialisation work needs to be done prior to p3 starting and I’d say u can pretty much guarantee that’s where r/d money is going
If they were going alone in p3, which I put at the same chance as lopez’s 6c CR (for a number of reasons) the ramp up costs in preparation for that would be much higher than 1.8 mill
Anyway u lot keep jumping at shadows it’s keeping me entertained while mgmt put a bow on this
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |